Research Topic · Peer-Reviewed

Immunosuppressive Therapy

Immunosuppressive therapy is the deliberate use of drugs and other interventions to reduce or modulate the activity of the immune system. It is central to Organ Transplantation, where it prevents the recipient's immune system from recognizing and rejecting the transplanted graft, and it is also used to treat autoimm…

Curated from this journal's research 📚 7 peer-reviewed articles cited Cited 37× across the literature 🔖 ISSN 2576-9359 🗓 Reviewed July 2026

Overview

Immunosuppressive therapy is the deliberate use of drugs and other interventions to reduce or modulate the activity of the immune system. It is central to Organ Transplantation, where it prevents the recipient's immune system from recognizing and rejecting the transplanted graft, and it is also used to treat autoimmune diseases, certain inflammatory conditions, and immune-mediated disorders such as immune thrombocytopenia. The therapy works by interfering with the immune pathways that drive rejection or self-directed attack, employing agents that target lymphocyte activation, proliferation, or signaling. In transplantation, regimens must balance adequate suppression to prevent acute rejection against the risks of over-suppression, and research increasingly seeks to personalize treatment, including the use of genetic markers such as single-nucleotide polymorphisms in patients with acute renal rejection to tailor drug choice and dosing. A defining challenge of immunosuppression is its effect on host defense: by dampening immunity, it heightens vulnerability to infection, including opportunistic and fungal infections such as mucormycosis seen in immunocompromised patients, as well as certain malignancies. Management therefore requires careful monitoring of drug levels, graft function, and complications, with laboratory tests guiding assessment of disease and response to therapy. Studying immunosuppressive therapy integrates transplantation medicine, immunology, and clinical pharmacology to understand how immune activity is controlled, how treatment is individualized, and how the benefits and risks of suppression are balanced.

Research published in this journal

7 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2019

A Rare Cause of Acute Renal Failure: Retroperitoneal Fibrosis

Caner EdizCorresponding author
Department of Urology, University of Health Sciences (Istanbul), Sultan Abdulhamid Han Education and Research Hospital, Istanbul, Turkey
Exact topic Clinical Case Reports and Images doi:10.14302/issn.2641-5518.jcci-19-3098

How this research is being cited

The 7 articles above have been cited 37 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Immunosuppressive Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Organ Transplantation (ISSN 2576-9359).

Journal editorial board
Francesca Diomede · Italy Luca Peruzzotti-Jametti · United Kingdom Karolina Golab · United States

This page summarises published research for orientation; it is not medical or professional advice.